Nancy Reau, MD: Larsucosterol for Alcohol-Associated Hepatitis
Phase 2b data from the AHFIRM trial is anticipated soon. Reau discusses what the agent may show in treating alcohol-associated hepatitis.
Stay updated with breaking news from Nancy Reau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2b data from the AHFIRM trial is anticipated soon. Reau discusses what the agent may show in treating alcohol-associated hepatitis.
A large cohort study using biopsy-proven cases confirms a link outside of known metabolic risk factors.
WEDNESDAY, June 14, 2023 (HealthDay News) -- Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical.
WEDNESDAY, June 14, 2023 (HealthDay News) -- Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical.
Hepatitis C is often missed in the early stages of infection, so you need to know what symptoms might spell trouble.